-
公开(公告)号:US20090313707A1
公开(公告)日:2009-12-17
申请号:US11814361
申请日:2006-05-18
申请人: Katherin E. Combs , Ling Ling Culbertson , Frederic J. de Sauvage , Zhiyong Ding , Joel Edwards , Rosemary Girgis , Allison A. B. Horner , Harald Junge , Jagath Reddy Junutula , Erin Marie Massey , Dina R. McLain , Charles Montgomery , Bobby Joe Payne , Heidi Phillips , Ni Nancy Qian , Carolina Rangel , Tracy E. W. Sevaux , Zheng-Zheng Shi , Mary Jean Sparks , Joy Anne Stala , Peter Vogel , Weilan Ye
发明人: Katherin E. Combs , Ling Ling Culbertson , Frederic J. de Sauvage , Zhiyong Ding , Joel Edwards , Rosemary Girgis , Allison A. B. Horner , Harald Junge , Jagath Reddy Junutula , Erin Marie Massey , Dina R. McLain , Charles Montgomery , Bobby Joe Payne , Heidi Phillips , Ni Nancy Qian , Carolina Rangel , Tracy E. W. Sevaux , Zheng-Zheng Shi , Mary Jean Sparks , Joy Anne Stala , Peter Vogel , Weilan Ye
CPC分类号: A01K67/0276 , A01K2217/075 , A01K2227/105 , A01K2267/03 , C12N15/8509
摘要: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 or PRO35250 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
摘要翻译: 本发明涉及转基因动物,以及与基因功能表征相关的组合物和方法。 具体地,本发明提供转基因小鼠,其包括PRO69122,PRO204,PRO214,PRO222,PRO234,PRO265,PRO309,PRO332,PRO342,PRO356,PRO540,PRO618,PRO944,PRO994,PRO1079,PRO1110,PRO1122,PRO1138,PRO1190,PRO1272中的中断 ,PRO1286,PRO1295,PRO1309,PRO1316,PRO1383,PRO1384,PRO1431,PRO1434,PRO1475,PRO1481,PRO1568,PRO1573,PRO1599,PRO1604,PRO1605,PRO1693,PRO1753,PRO1755,PRO1777,PRO1788,PRO1864,PRO1925,PRO1926,PRO3566,PRO4330。 ,PRO4423,PRO36935,PRO4977,PRO4979,PRO4980,PRO4981,PRO5801,PRO5995,PRO6001,PRO6095,PRO6182,PRO7170,PRO7171,PRO7436,PRO9912,PRO9917,PRO37337,PRO37496,PRO19646,PRO21718,PRO19820,PRO21201,PRO20026,PRO20110,PRO23203 或PRO35250基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防,改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管,内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。
-
2.
公开(公告)号:US20120030776A1
公开(公告)日:2012-02-02
申请号:US12910746
申请日:2010-10-22
申请人: Katherin E. Combs , Ling Ling Culbertson , Frederic de Sauvage , Zhiyong Ding , Joel Edwards , Rosemary Girgis , Allison Anne Byers Horner , Harald Junge , Jagath Reddy Junutula , Erin Marie Massey , Dina Rebecca McLain , Charles Montgomery , Bobby Joe Payne , Heidi Phillips , Ni Nancy Qian , Carolina Rangel , Tracy Ellen Willis Sevaux , Zheng-Zheng Shi , Mary Jean Sparks , Joy Anne Stala , Peter Vogel , Weilan Ye
发明人: Katherin E. Combs , Ling Ling Culbertson , Frederic de Sauvage , Zhiyong Ding , Joel Edwards , Rosemary Girgis , Allison Anne Byers Horner , Harald Junge , Jagath Reddy Junutula , Erin Marie Massey , Dina Rebecca McLain , Charles Montgomery , Bobby Joe Payne , Heidi Phillips , Ni Nancy Qian , Carolina Rangel , Tracy Ellen Willis Sevaux , Zheng-Zheng Shi , Mary Jean Sparks , Joy Anne Stala , Peter Vogel , Weilan Ye
CPC分类号: A01K67/0276 , A01K2217/075 , A01K2227/105 , A01K2267/03 , C12N15/8509
摘要: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO69122, PRO204, PRO214, PRO222, PRO234, PRO265, PRO309, PRO332, PRO342, PRO356, PRO540, PRO618, PRO944, PRO994, PRO1079, PRO1110, PRO1122, PRO1138, PRO1190, PRO1272, PRO1286, PRO1295, PRO1309, PRO1316, PRO1383, PRO1384, PRO1431, PRO1434, PRO1475, PRO1481, PRO1568, PRO1573, PRO1599, PRO1604, PRO1605, PRO1693, PRO1753, PRO1755, PRO1777, PRO1788, PRO1864, PRO1925, PRO1926, PRO3566, PRO4330, PRO4423, PRO36935, PRO4977, PRO4979, PRO4980, PRO4981, PRO5801, PRO5995, PRO6001, PRO6095, PRO6182, PRO7170, PRO7171, PRO7436, PRO9912, PRO9917, PRO37337, PRO37496, PRO19646, PRO21718, PRO19820, PRO21201, PRO20026, PRO20110, PRO23203 or PRO35250 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
摘要翻译: 本发明涉及转基因动物,以及与基因功能表征相关的组合物和方法。 具体地,本发明提供转基因小鼠,其包括PRO69122,PRO204,PRO214,PRO222,PRO234,PRO265,PRO309,PRO332,PRO342,PRO356,PRO540,PRO618,PRO944,PRO994,PRO1079,PRO1110,PRO1122,PRO1138,PRO1190,PRO1272中的中断 ,PRO1286,PRO1295,PRO1309,PRO1316,PRO1383,PRO1384,PRO1431,PRO1434,PRO1475,PRO1481,PRO1568,PRO1573,PRO1599,PRO1604,PRO1605,PRO1693,PRO1753,PRO1755,PRO1777,PRO1788,PRO1864,PRO1925,PRO1926,PRO3566,PRO4330 ,PRO4423,PRO36935,PRO4977,PRO4979,PRO4980,PRO4981,PRO5801,PRO5995,PRO6001,PRO6095,PRO6182,PRO7170,PRO7171,PRO7436,PRO9912,PRO9917,PRO37337,PRO37496,PRO19646,PRO21718,PRO19820,PRO21201,PRO20026,PRO20110,PRO23203 或PRO35250基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防,改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管,内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。
-
3.
公开(公告)号:US20110097330A1
公开(公告)日:2011-04-28
申请号:US11722967
申请日:2006-02-27
申请人: Allison Anne Byers Horner , Catherine Batac Clarke , Katherin E. Combs , Frederic J. de Sauvage , Joel Edwards , Paul Godowski , Deanna Grant Wilson , Wenhu Huang , Lorelei Diane Ketcherside , Erin Marie Massey , Charles Montgomery , Bobby Joe Payne , Andrew Peterson , Ni Nancy Qian , Jeffrey J. Schrick , Zheng-Zheng Shi , Mary Jean Sparks , Joy Anne Stala , Colleen M. Viator , Peter Vogel , Weilan Ye , Jung-Hua Yeh , Zhiyong Ding
发明人: Allison Anne Byers Horner , Catherine Batac Clarke , Katherin E. Combs , Frederic J. de Sauvage , Joel Edwards , Paul Godowski , Deanna Grant Wilson , Wenhu Huang , Lorelei Diane Ketcherside , Erin Marie Massey , Charles Montgomery , Bobby Joe Payne , Andrew Peterson , Ni Nancy Qian , Jeffrey J. Schrick , Zheng-Zheng Shi , Mary Jean Sparks , Joy Anne Stala , Colleen M. Viator , Peter Vogel , Weilan Ye , Jung-Hua Yeh , Zhiyong Ding
IPC分类号: A61K49/00 , C07K16/18 , A61K39/00 , A61P25/00 , A61P9/00 , A61P37/00 , A61P27/02 , A61P25/24 , A61P25/22 , A61P25/18 , A61P27/06 , A61P27/12 , A61P9/10 , A61P19/02 , A61P19/10 , C12Q1/68 , C12N5/071 , C12N5/0735 , C12Q1/02
CPC分类号: C07K14/47 , A01K2217/075 , A61K2039/505 , G01N2500/00
摘要: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO179, PRO181, PRO244, PRO247, PRO269, PRO293, PRO298, PRO339, PRO341, PRO347, PRO531, PRO537, PRO718, PRO773, PRO860, PRO871, PRO872, PRO813, PRO828, PRO1100, PRO1114, PRO115, PRO1126, PRO1133, PRO1154, PRO1185, PRO1194, PRO1287, PRO1291, PRO1293, PRO1310, PRO1312, PRO1335, PRO1339, PRO2155, PRO1356, PRO1385, PRO1412, PRO1487, PRO1758, PRO1779, PRO1785, PRO1889, PRO90318, PRO3434, PRO3579, PRO4322, PRO4343, PRO4347, PRO4403, PRO4976, PRO260, PRO6014, PRO6027, PRO6181, PRO6714, PRO9922, PRO7179, PRO7476, PRO9824, PRO19814, PRO19836, PRO20088, PRO70789, PRO50298, PRO51592, PRO1757, PRO4421, PRO9903, PRO1106, PRO1411, PRO1486, PRO1565, PRO4399 or PRO4404 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
摘要翻译: 本发明涉及转基因动物,以及与基因功能表征相关的组合物和方法。 具体地说,本发明提供转基因小鼠,其包括PRO179,PRO181,PRO244,PRO247,PRO269,PRO293,PRO298,PRO339,PRO341,PRO347,PRO531,PRO537,PRO718,PRO773,PRO860,PRO871,PRO872,PRO813,PRO828,PRO1100中的中断 ,PRO1114,PRO115,PRO1126,PRO1133,PRO1154,PRO1185,PRO1194,PRO1287,PRO1291,PRO1293,PRO1310,PRO1312,PRO1335,PRO1339,PRO2155,PRO1356,PRO1385,PRO1412,PRO1487,PRO1758,PRO1779,PRO1785,PRO1889,PRO90318,PRO3434 ,PRO3579,PRO4322,PRO4343,PRO4347,PRO4403,PRO4976,PRO260,PRO6014,PRO6027,PRO6181,PRO6714,PRO9922,PRO7179,PRO7476,PRO9824,PRO19814,PRO19836,PRO20088,PRO70789,PRO50298,PRO51592,PRO1757,PRO4421,PRO9903,PRO1106 ,PRO1411,PRO1486,PRO1565,PRO4399或PRO4404基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防,改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管,内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。
-
公开(公告)号:US20090196876A1
公开(公告)日:2009-08-06
申请号:US11577547
申请日:2005-10-18
申请人: Fred de Sauvage , Dorothy French , Lino Gonzalez , Asja Praetor , Weilan Ye , Katherin E. Combs , Zhiyong Ding , Allison Anne Byers Horner , Erin Marie Massey , Charles Montgomery , Laurie Jeanette Minze , Carolina Rangel , Tracy Ellen Willis Sevaux , Zheng-Zheng Shi , Mary Jean Sparks , Joy Anne Stala , Peter Vogel
发明人: Fred de Sauvage , Dorothy French , Lino Gonzalez , Asja Praetor , Weilan Ye , Katherin E. Combs , Zhiyong Ding , Allison Anne Byers Horner , Erin Marie Massey , Charles Montgomery , Laurie Jeanette Minze , Carolina Rangel , Tracy Ellen Willis Sevaux , Zheng-Zheng Shi , Mary Jean Sparks , Joy Anne Stala , Peter Vogel
IPC分类号: A61K39/395 , G01N33/00 , C12N5/10 , C07K16/18 , A61P27/00 , A61P25/00 , A61P25/18 , A61P25/22 , A61P37/00 , A61P13/12 , A61P3/00 , A61P19/00 , A61P9/00 , A61P35/00 , A61P41/00 , A61P3/10
CPC分类号: A01K67/0276 , A01K2217/075 , A01K2227/105 , A01K2267/035
摘要: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO194, PRO220, PRO241, PRO284, PRO331, PRO354, PRO355, PRO533, PRO541, PRO725, PRO937, PRO1014, PRO1120, PRO1182, PRO1325, PRO1382, PRO1410, PRO1555, PRO1556, PRO1760, PRO1787, PRO1868, PRO4326, PRO4332, PRO4346, PRO4400, PRO6003, PRO6094, PRO6244, PRO9820, PRO9828, PRO10274, PRO16090, PRO19644, PRO21340, PRO92165, PRO85143, PRO1124, PRO1026 or PRO23370 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
摘要翻译: 本发明涉及转基因动物,以及与基因功能表征相关的组合物和方法。 具体地,本发明提供转基因小鼠,其包括PRO194,PRO220,PRO241,PRO284,PRO331,PRO354,PRO355,PRO533,PRO541,PRO725,PRO937,PRO1014,PRO1120,PRO1182,PRO1325,PRO1382,PRO1410,PRO1555,PRO1556,PRO1760中的中断 ,PRO1787,PRO1868,PRO4326,PRO4332,PRO4346,PRO4400,PRO6003,PRO6094,PRO6244,PRO9820,PRO9828,PRO10274,PRO16090,PRO19644,PRO21340,PRO92165,PRO85143,PRO1124,PRO1026或PRO23370基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防,改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管,内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。
-
5.
公开(公告)号:US20120210450A1
公开(公告)日:2012-08-16
申请号:US13082706
申请日:2011-04-08
申请人: Fred de Sauvage , Dorothy French , Lino Gonzalez , Asja Praetor , Weilan Ye , Katherin E. Combs , Zhiyong Ding , Allison Anne Byers Horner , Erin Marie Massey , Charles Montgomery , Laurie Jeanette Minze , Carolina Rangel , Tracy Ellen Willis Sevaux , Zheng-Zheng Shi , Mary Jean Sparks , Joy Anne Stala , Peter Vogel
发明人: Fred de Sauvage , Dorothy French , Lino Gonzalez , Asja Praetor , Weilan Ye , Katherin E. Combs , Zhiyong Ding , Allison Anne Byers Horner , Erin Marie Massey , Charles Montgomery , Laurie Jeanette Minze , Carolina Rangel , Tracy Ellen Willis Sevaux , Zheng-Zheng Shi , Mary Jean Sparks , Joy Anne Stala , Peter Vogel
IPC分类号: G01N33/48
CPC分类号: A01K67/0276 , A01K2217/075 , A01K2227/105 , A01K2267/035
摘要: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO194, PRO220, PRO241, PRO284, PRO331, PRO354, PRO355, PRO533, PRO541, PRO725, PRO937, PRO1014, PRO1120, PRO1182, PRO1325, PRO1382, PRO1410, PRO1555, PRO1556, PRO1760, PRO1787, PRO1868, PRO4326, PRO4332, PRO4346, PRO4400, PRO6003, PRO6094, PRO6244, PRO9820, PRO9828, PRO10274, PRO16090, PRO19644, PRO21340, PRO92165, PRO85143, PRO1124, PRO1026 or PRO23370 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
摘要翻译: 本发明涉及转基因动物,以及与基因功能表征相关的组合物和方法。 具体地,本发明提供转基因小鼠,其包括PRO194,PRO220,PRO241,PRO284,PRO331,PRO354,PRO355,PRO533,PRO541,PRO725,PRO937,PRO1014,PRO1120,PRO1182,PRO1325,PRO1382,PRO1410,PRO1555,PRO1556,PRO1760中的中断 ,PRO1787,PRO1868,PRO4326,PRO4332,PRO4346,PRO4400,PRO6003,PRO6094,PRO6244,PRO9820,PRO9828,PRO10274,PRO16090,PRO19644,PRO21340,PRO92165,PRO85143,PRO1124,PRO1026或PRO23370基因。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防,改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管,内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。
-
6.
公开(公告)号:US20120174239A1
公开(公告)日:2012-07-05
申请号:US13317754
申请日:2011-10-27
申请人: Stephen Jay Anderson , Jane Brennan , Frederic J. de Sauvage , Zhiyong Ding , Joel Edwards , Nelda A. Fikes , Wenhu Huang , Wenjun Ouyang , Carolina Rangel , Mamta Sangha , Zheng-Zheng Shi , Mary Jean Sparks , Joseph Trackey , Melissa Vetter , Ching-Yun Wang , Jessica Woodings
发明人: Stephen Jay Anderson , Jane Brennan , Frederic J. de Sauvage , Zhiyong Ding , Joel Edwards , Nelda A. Fikes , Wenhu Huang , Wenjun Ouyang , Carolina Rangel , Mamta Sangha , Zheng-Zheng Shi , Mary Jean Sparks , Joseph Trackey , Melissa Vetter , Ching-Yun Wang , Jessica Woodings
IPC分类号: G01N21/64 , G01N23/083 , C40B30/04 , G01N33/53
CPC分类号: A01K67/0276 , A01K2217/075 , A01K2227/105 , A01K2267/0306
摘要: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO224, PRO9783, PRO1108, PRO34000, PRO240, PRO943, hu A33, PRO230, PRO178, PRO1199, PRO4333, PRO1336, PRO19598, PRO1083, hu TRPM2 or PRO1801 genes.Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
摘要翻译: 本发明涉及转基因动物,以及与基因功能表征相关的组合物和方法。 具体地说,本发明提供包含PRO224,PRO9783,PRO1108,PRO34000,PRO240,PRO943,hu A33,PRO230,PRO178,PRO1199,PRO4333,PRO1336,PRO19598,PRO1083,hu TRPM2或PRO1801基因中的中断的转基因小鼠。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防,改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管,内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。
-
公开(公告)号:US20070292438A1
公开(公告)日:2007-12-20
申请号:US10583466
申请日:2004-12-13
申请人: Stephen Anderson , Jane Brennan , Frederic de Sauvage , Zhiyong Ding , Joel Edwards , Nelda Fikes , Wenhu Huang , Wenjun Ouyang , Carolina Rangel , Mamta Sangha , Zheng-Zheng Shi , Mary Sparks , Joseph Trackey , Melissa Vetter , Ching-Yun Wang , Jessica Woodings
发明人: Stephen Anderson , Jane Brennan , Frederic de Sauvage , Zhiyong Ding , Joel Edwards , Nelda Fikes , Wenhu Huang , Wenjun Ouyang , Carolina Rangel , Mamta Sangha , Zheng-Zheng Shi , Mary Sparks , Joseph Trackey , Melissa Vetter , Ching-Yun Wang , Jessica Woodings
CPC分类号: A01K67/0276 , A01K2217/075 , A01K2227/105 , A01K2267/0306
摘要: The present invention relates to transgenic animals, as well as compositions and methods relating to the characterization of gene function. Specifically, the present invention provides transgenic mice comprising disruptions in PRO224, PRO9783, PRO1108, PRO34000, PRO240, PRO943, hu A33, PRO230, PRO178, PRO1199, PRO4333, PRO1336, PRO19598, PRO1083, hu TRPM2 or PRO1801 genes. Such in vivo studies and characterizations may provide valuable identification and discovery of therapeutics and/or treatments useful in the prevention, amelioration or correction of diseases or dysfunctions associated with gene disruptions such as neurological disorders; cardiovascular, endothelial or angiogenic disorders; eye abnormalities; immunological disorders; oncological disorders; bone metabolic abnormalities or disorders; lipid metabolic disorders; or developmental abnormalities.
摘要翻译: 本发明涉及转基因动物,以及与基因功能表征相关的组合物和方法。 具体地说,本发明提供包含PRO224,PRO9783,PRO1108,PRO34000,PRO240,PRO943,hu A33,PRO230,PRO178,PRO1199,PRO4333,PRO1336,PRO19598,PRO1083,hu TRPM2或PRO1801基因中的中断的转基因小鼠。 这样的体内研究和表征可以提供有用的识别和发现治疗和/或治疗用于预防,改善或矫正与基因中断相关的疾病或功能障碍如神经障碍; 心血管,内皮或血管生成障碍; 眼睛异常; 免疫学障碍; 肿瘤疾病; 骨代谢异常或障碍; 脂代谢紊乱 或发育异常。
-
8.METHODS AND COMPOSITIONS RELATED TO IDENTIFYING PROTEIN-PROTEIN INTERACTIONS 审中-公开
标题翻译: 鉴定蛋白质 - 蛋白质相互作用相关的方法和组合公开(公告)号:US20090221440A1
公开(公告)日:2009-09-03
申请号:US11572088
申请日:2005-07-12
申请人: Zhiyong Ding , Gordon Mills
发明人: Zhiyong Ding , Gordon Mills
CPC分类号: C12N15/1055
摘要: The present invention involves compositions and methods for assessing protein interactions in eukaryotic cells. Certain embodiments involve Retrovirus-Based Molecular Two-Hybrid Screens (ReMTH). ReMTH screens differ from other methods by performing screens in the native cellular hosts without cDNA library construction. Embodiments of the invention use the advantages of tagging endogenous genes with an exon encoding a marker fragment in combination with protein-fragment complementation assays (PCAs), which includes the complementation of at least two marker fragments to form a detectable marker complex. ReMTH vectors insert a nucleotide sequence encoding a first fragment of a marker, such as green fluorescent protein (GFP), into an endogenous gene resulting in expression of random endogenous genes tagged with a first marker fragment forming an endogenous prey protein or prey protein. ReMTH contain cells also express a bait protein that is fused with a second marker fragment. Prey/Bait interaction produces a reconstituted, detectable marker.
摘要翻译: 本发明涉及用于评估真核细胞中蛋白质相互作用的组合物和方法。 某些实施方案涉及基于逆转录病毒的分子双杂交筛选(ReMTH)。 ReMTH屏幕与其他方法不同,通过在没有cDNA文库构建的天然细胞宿主中进行筛选。 本发明的实施方案利用将编码标记片段的外显子与蛋白质 - 片段互补测定(PCAs)结合的内源基因标记的优点,其包括至少两个标记片段的互补以形成可检测的标记物复合物。 ReMTH载体将编码标记物的第一片段(例如绿色荧光蛋白(GFP))的核苷酸序列插入到内源基因中,导致用形成内源猎物蛋白质或猎物蛋白质的第一标记片段标记的随机内源基因的表达。 含有细胞的ReMTH还表达与第二标记片段融合的诱饵蛋白质。 捕食/诱饵相互作用产生重建的可检测标记。
-
-
-
-
-
-
-